C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2004
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825191 Benzodiazepine derivatives
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/25/2004	WO2004101553A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004	WO2004101551A1 Crystal of benzimidazole derivative and process for producing the same
11/25/2004	WO2004101549A1 2-anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors
11/25/2004	WO2004101544A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	WO2004101533A1 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
11/25/2004	WO2004101523A1 Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
11/25/2004	WO2004101520A1 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists
11/25/2004	WO2004101506A1 Glyoxalase inhibitors
11/25/2004	WO2004100998A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/25/2004	WO2004100960A2 Anti-inflammatory phosphonate compounds
11/25/2004	WO2004100946A1 1- (2h-pyrazol -3-yl) -3yl) {4-`1- (benzoyl) -piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhbitors of p38 kinase and/or tnf inhibitors for the treatment of imflammations
11/25/2004	WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
11/25/2004	WO2004054498A3 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
11/25/2004	WO2004043379A3 Chemical compounds
11/25/2004	US20040236116 Novel bicyclic and tricyclic cannabinoids
11/25/2004	US20040236114 1-[(hetero)aryloxy- or -thio-hydroxyalkyl]-substituted imidazole-4-carboxamides, e.g., 1-(5-(1,1'-biphenyl-3-yloxy)-2-hydroxy-3-pentyl]imidazole-4-carboxamide; treating rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis, sunburn, eczema, conjunctivitis, asthma, & bronchitis
11/25/2004	US20040236110 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
11/25/2004	US20040236109 Tetrahydroquinoline derivatives
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040235958 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
11/25/2004	US20040235927 Synthesis and antimicrobial activity of novel dicationic "reversed amidines"
11/25/2004	US20040235914 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants
11/25/2004	US20040235897 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235891 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders
11/25/2004	US20040235888 Utilities of amide compounds
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235852 Benzofuran inhibitors of factor VIIa
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235832 Sexual diosrders; schizophrenia; drug abuse; eating disorders anxiolytic agents
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235821 Novel compounds
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004	US20040235667 Pyrazolyl-substituted thienyloxypyridines
11/25/2004	CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/25/2004	CA2525858A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2525438A1 Glyoxalase inhibitors
11/25/2004	CA2524958A1 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	CA2524434A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	CA2523978A1 Crystal of benzimidazole derivative and process for producing the same
11/24/2004	EP1479678A1 Pyrazole-derivatives as factor xa inhibitors
11/24/2004	EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1479671A1 Pyrimidinone compounds
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478628A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478364A2 Selective antibacterial agents
11/24/2004	EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1548428A Carboxylic acid derivatives having fused rings
11/24/2004	CN1176907C Substituted pyridine herbicides
11/23/2004	US6822384 Design and synthesis of advanced NLO materials for electro-optic applicators
11/23/2004	US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821992 Fungicides
11/23/2004	US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004	US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004	US6821646 Capable of providing a high-efficiency luminescent state at a high brightness (or luminance) for a long period while minimizing the deterioration in luminescence in energized state
11/18/2004	WO2004099195A1 3-carbonylaminothiophenes and their use as fungicides
11/18/2004	WO2004099192A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099191A2 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors
11/18/2004	WO2004099185A1 2-cyanopyrrolidine derivatives and their use as dpp-iv inhibitors
11/18/2004	WO2004099159A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	WO2004099127A1 Novel compounds as kinase inhibitors
11/18/2004	WO2004099126A1 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
11/18/2004	WO2004098590A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098589A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004074246A3 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229918 Phosphodiesterase 4 inhibitors
11/18/2004	US20040229915 Cysteine protease inhibitors
11/18/2004	US20040229909 Antiviral agent
11/18/2004	US20040229892 HIV integrase inhibitors
11/18/2004	US20040229889 HDAC inhibitor
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229871 Nitrogen compounds such as 2-(5-(4-Fluoro-benzyloxy)-1,3-dioxo -1,3-dihydro-isoindol-2-yl)-acetamide, used for prophylaxis of Alzheimer's disease; amine oxidase inhibitors
11/18/2004	US20040229868 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229863 Administering 4-amino-azepan-3-one compound for inhibiting cathepsin S
11/18/2004	US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004	US20040229859 Beta-amino acid compounds as integrin antagonists
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040229840 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/18/2004	CA2524508A1 3-carbonylaminothiophenes and their use as fungicides
11/18/2004	CA2524324A1 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhibitors

1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 523